An approach to synthetic vaccine design is illustrated, focusing on the immunodominant (NPNA)n repeat region of the circumsporozoite (CS) protein of the malaria parasite Plasmodium falciparum. Modelling suggests that the NPNAN motif may adopt a helical β-turn, which is tandemly repeated in the CS protein to generate a novel supersecondary structure. Cyclic peptidomimetics of this NPNAN motif were synthesized and shown by NMR to adopt helical turns in aqueous solution. When incorporated into Immunopotentiating Reconstituted Influenza Virosomes (IRIVs), humoral immune responses were generated in mice that crossreact with native CS protein on sporozoites. IRIVs are a human-compatible delivery system that appear generally suitable for inducing ...
RTS,S is the leading malaria vaccine in development, but has demonstrated only moderate protective e...
The circumsporozoite (CS) protein is a major malaria sporozoite surface antigen currently being cons...
Since variolation, conventional approaches to vaccine development are based on live-attenuated, inac...
Item does not contain fulltextThe circumsporozoite protein (CSP) of Plasmodium falciparum is a leadi...
SummaryThe circumsporozoite protein (CSP) of Plasmodium falciparum is a leading candidate antigen fo...
The molecular basis for obtaining novel anti-malarial vaccine candidates depends on a considered sel...
The peptide CS.T3, corresponding to residues 378-398 of the Plasmodium falciparum (Pf) circumsporozo...
Macromolecular structures represent an interesting starting point for the design and synthesis of sm...
Synthetic vaccines constitute the most promising tools for controlling and preventing infectious dis...
Synthetic vaccines constitute the most promising tools for controlling and preventing infectious dis...
The malaria vaccine candidate merozoite surface protein 2 (MSP2) has shown promise in clinical trial...
Rational strategies for obtaining malaria vaccine candidates should include not only a proper select...
Protein epitope mimetics provide powerful tools to study biomolecular recognition in many areas of c...
The circumsporozoite protein (CSP) of the malaria parasite Plasmodium vivax is a major pre-erythrocy...
Development of a highly effective vaccine or antibodies for the prevention and ultimately eliminatio...
RTS,S is the leading malaria vaccine in development, but has demonstrated only moderate protective e...
The circumsporozoite (CS) protein is a major malaria sporozoite surface antigen currently being cons...
Since variolation, conventional approaches to vaccine development are based on live-attenuated, inac...
Item does not contain fulltextThe circumsporozoite protein (CSP) of Plasmodium falciparum is a leadi...
SummaryThe circumsporozoite protein (CSP) of Plasmodium falciparum is a leading candidate antigen fo...
The molecular basis for obtaining novel anti-malarial vaccine candidates depends on a considered sel...
The peptide CS.T3, corresponding to residues 378-398 of the Plasmodium falciparum (Pf) circumsporozo...
Macromolecular structures represent an interesting starting point for the design and synthesis of sm...
Synthetic vaccines constitute the most promising tools for controlling and preventing infectious dis...
Synthetic vaccines constitute the most promising tools for controlling and preventing infectious dis...
The malaria vaccine candidate merozoite surface protein 2 (MSP2) has shown promise in clinical trial...
Rational strategies for obtaining malaria vaccine candidates should include not only a proper select...
Protein epitope mimetics provide powerful tools to study biomolecular recognition in many areas of c...
The circumsporozoite protein (CSP) of the malaria parasite Plasmodium vivax is a major pre-erythrocy...
Development of a highly effective vaccine or antibodies for the prevention and ultimately eliminatio...
RTS,S is the leading malaria vaccine in development, but has demonstrated only moderate protective e...
The circumsporozoite (CS) protein is a major malaria sporozoite surface antigen currently being cons...
Since variolation, conventional approaches to vaccine development are based on live-attenuated, inac...